Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Medication details

Concurrent Medications. Details of other drugs including formulation, dose and duration. [Pg.848]

The Motherisk protocol allowed us to record in a systematic manner all exposure data and other maternal and paternal medical details at the time of exposure during the first trimester of pregnancy and to follow up pregnancy outcomes prospectively in this eohort. The control group was assessed in an identical manner. [Pg.1346]

Start with medication details drugs, doses, planned increases... [Pg.492]

Si, A1,0 and H)). Steel reinforcing can be easily detected and studied in detail in concrete 1000 mm thick and more. For this purpose it is possible to use rapid medical x-ray film, requiring exposure times of 6 to 26 minutes for concrete tliicknesses of 600 and 900 mm respeetively. [Pg.1002]

Full details of this work were pubHshed (6) and the processes, or variants of them, were introduced in a number of other countries. In the United States, the pharmaceutical industry continued to provide manufacturing sites, treating plasma fractionation as a normal commercial activity. In many other countries processing was undertaken by the Red Cross or blood transfusion services that emerged following Wodd War II. In these organisations plasma fractionation was part of a larger operation to provide whole blood, blood components, and speciaUst medical services on a national basis. These different approaches resulted in the development of two distinct sectors in the plasma fractionation industry ie, a commercial or for-profit sector based on paid donors and a noncommercial or not-for-profit sector based on unpaid donors. [Pg.526]

Toxicity Data on Af- Vinyl-2-Pyrrolidinone. Results of a chronic inhalation study in rats warrant a review of industrial hygiene practices to assure that VP vapor concentrations are maintained at a safe level. One of the manufacturers, ISP, recommends that an appropriate workplace exposure limit be set at 0.1 ppm (vapor) (9). Additionally, normal hygienic practices and precautions are recommended, such as prompt removal from skin and avoidance of ingestion. In case of accidental eye contact, immediately flush with water for at least 15 minutes and seek medical attention. Refer to the manufacturers Material Safety Data Sheets for more detailed information. Table 3 provides some toxicity data. [Pg.523]

The use of safe materials is vital for barrier appHcations, particularly for food, medical, and cosmetics packaging. SuppHers of specific barrier polymers can provide the necessary details, such as material safety data sheets, to ensure safe processing and use of barrier polymers. [Pg.501]

History. Detailed reviews of biological, chemical, and clinical research that led to the introduction of oral contraceptives are available in the scientific and medical literature (8,9). [Pg.111]

The cyanine class of dyes is also useful in biological, medical, laser, and electro-optic appHcations. Dyes marketed as Povan [3546-41-6] (5) and Dithiazanine [7187-55-5] (6) are useful anthelmintics, and Indocyanine Green [3599-32-4] (7) is an infrared-absorbing tracer for blood-dilution medical diagnoses. "Stains-AU." is a weU-studied biological stain (8) and Merocyanine 540 s photochemotherapeutic activity is known in some detail (9). Many commercially available red and infrared laser dyes are cyanines (10). [Pg.389]

Pure Ethanol. Undenatured ethanol can be bought on either a tax-free or tax-paid basis. Approved educational, scientific or medical organizations and pubHc agencies can buy tax-free alcohol. Use and withdrawal permits are required, as are a bond and detailed records. Resale of tax-free ethanol is prohibited. Approved industrial uses for pure tax-paid ethanol include pharmaceuticals, cosmetics, flavoring extracts, and foods. [Pg.414]

Table 3 lists the structures and generic names of the principal penicillins in current medical usage, and Table 4 indicates in summary form the relative antibacterial properties of these compounds. The reader is urged to consult reviews such as (B-77MI51106) for a more complete treatment, since summaries such as Table 4 inevitably omit a large amount of important detail. [Pg.336]

As can be seen from Table 3, only modifications at the 6/3-amino groups have been successful in producing penicillins of medical significance up to this time. Several reviews have dealt with the structure-activity relationship in this area in considerable detail B-80MI51102, B-77MI51106, B-75MI51102) and should be consulted for the actual effects of structural modification on antibacterial activity. [Pg.338]

Chemical composition details of ingredients, formulae and proportions, including measures to be taken for over-exposure to eyes/skin or by inhalation/ingestion/absorption. Information for medical treatment. [Pg.457]

In 1937 Krebs found that citrate could be formed in muscle suspensions if oxaloacetate and either pyruvate or acetate were added. He saw that he now had a cycle, not a simple pathway, and that addition of any of the intermediates could generate all of the others. The existence of a cycle, together with the entry of pyruvate into the cycle in the synthesis of citrate, provided a clear explanation for the accelerating properties of succinate, fumarate, and malate. If all these intermediates led to oxaloacetate, which combined with pyruvate from glycolysis, they could stimulate the oxidation of many substances besides themselves. (Kreb s conceptual leap to a cycle was not his first. Together with medical student Kurt Henseleit, he had already elucidated the details of the urea cycle in 1932.) The complete tricarboxylic acid (Krebs) cycle, as it is now understood, is shown in Figure 20.4. [Pg.642]

A series of polyester-based TPU (566TPU series) were synthesized in our lab and used to blend with PVC to manufacture a modified PVC material for medical uses [14]. Morphological studies showed that 566TPU has very good compatibility with PVC. Detailed mechanical and electronic property tests were also conducted. Some of the data are provided in Tables 3 and 4. [Pg.143]


See other pages where Medication details is mentioned: [Pg.4]    [Pg.140]    [Pg.178]    [Pg.233]    [Pg.317]    [Pg.4]    [Pg.140]    [Pg.178]    [Pg.233]    [Pg.317]    [Pg.209]    [Pg.1625]    [Pg.593]    [Pg.312]    [Pg.314]    [Pg.26]    [Pg.232]    [Pg.77]    [Pg.398]    [Pg.53]    [Pg.132]    [Pg.458]    [Pg.460]    [Pg.383]    [Pg.458]    [Pg.19]    [Pg.530]    [Pg.304]    [Pg.428]    [Pg.21]    [Pg.196]    [Pg.206]    [Pg.392]    [Pg.308]    [Pg.285]    [Pg.734]    [Pg.532]   
See also in sourсe #XX -- [ Pg.26 ]




SEARCH



© 2024 chempedia.info